Get the Stockscreener App
0.1311
8.19%
-0.0117
Vivos Therapeutics Inc stock is traded at $0.1311, with a volume of 1.62M.
It is down -8.19% in the last 24 hours and down -18.62% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$0.1428
Open:
$0.1427
24h Volume:
1.62M
Relative Volume:
0.59
Market Cap:
$2.64M
Revenue:
$19.57M
Net Income/Loss:
$-25.12M
P/E Ratio:
-0.0567
EPS:
-2.3114
Net Cash Flow:
$-19.71M
1W Performance:
-11.95%
1M Performance:
-18.62%
6M Performance:
-87.97%
1Y Performance:
-95.46%
1-Day Range:
$0.1278
$0.1427
1-Week Range:
$0.1276
$0.1501
52-Week Range:
$0.1276
$3.21
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
0.1311 | 2.64M | 19.57M | -25.12M | -19.71M | -2.3114 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com Canada
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com South Africa
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com India
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com UK
ME Therapeutics Holdings (CN:METX:CNX) Stock Rebounds 14.29%: In Vivo CAR-T and mRNA STING Program Pacing, Micro-Cap Liquidity Dynamics, and Preclinical Biotech Re-Rating Examined - kalkine.ca
TScan Therapeutics (Nasdaq:TCRX)Stock Analysis - simplywall.st
Director at Vivos Therapeutics (VVOS) receives 12,000 stock options - Stock Titan
[Form 4] Vivos Therapeutics, Inc. Insider Trading Activity - Stock Titan
VVOS Form 4 FilingsVivos Therapeutics, Inc. SEC Form 4 - Stock Titan
Vivos Therapeutics (VVOS) grants director 12,000 options - Stock Titan
TPST Stock Spikes As Tempest Therapeutics Expands In Vivo CAR-T Pipeline - timothysykes.com
Vivos Issues 11.45M Shares to Retire $2.86M of Debt in Dilutive Exchange - Minichart
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com Nigeria
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com South Africa
Vivos to Issue 11.4M Shares to Settle $2.86M in Debt - minichart.com.sg
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com Canada
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com India
Vivos exchanges $2.9m debt for common stock with Streeterville - Investing.com
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com UK
Vivos Therapeutics Announces Material Debt Reduction - The Manila Times
Vivos Therapeutics Announces Material Debt Reduction - Yahoo Finance
Vivos Therapeutics Swaps $2.86M of Streeterville Debt for Up to 11.45M Shares - TradingView
Vivos Therapeutics (VVOS) investor lists 122,963 shares, under 5% - Stock Titan
Regional Sleep & Airway Medicine Center to Be Established in Palm Beach County, Fla - Sleep Review
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference - marketscreener.com
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference - TradingView
Vivos CEO to present at 2026 Moody Capital Solu... - Pluang
Vivos Therapeutics Surges as Investors Weigh Nevada Growth Updates and Florida Expansion Plan - Moomoo
Vivos Therapeutics Surges as Investors Weigh Nevada Growth Updates and Florida Expansion Plan - Quiver Quantitative
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center - The Manila Times
Vivos Therapeutics partners with Florida cardiology group for sleep center - Investing.com
Vivos Therapeutics partners with Florida cardiology group for sleep center - Investing.com India
Vivos Therapeutics partners with Florida cardiology group for sleep center By Investing.com - Investing.com UK
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center - marketscreener.com
Vivos plans a Florida sleep center built to treat 250 patients a month - Stock Titan
Vivos Therapeutics Inc. (VVOS) Peer Comparison – Compare with Others - Value Research
Vivos Therapeutics (VVOS) grants 250K shares, 150K options - Stock Titan
Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com Canada
Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com India
Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com UK
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers - Barchart.com
Vivos' Nevada sleep referrals rose 212% before a new center opens - Stock Titan
Vivos Therapeutics Reports 212% Increase in Nevada Sleep & Airway Medicine Center Referrals Ahead of Henderson Facility Opening - Quiver Quantitative
Vivos Therapeutics Inc (VVOS) Stock News Today - TradingKey
Vivos Therapeutics opens Henderson facility with $10M capacity - Investing.com
Vivos Therapeutics Opens Nevada Sleep Treatment Center - marketscreener.com
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment - The Manila Times
Vivos Therapeutics opens Henderson facility with $10M capacity By Investing.com - Investing.com Canada
Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually - Moomoo
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.88%
22.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):